1997•European UrologyRequires access

Clinical Evaluation of Nuclear Matrix Protein 22 (NMP22) in Urine as a Novel Marker for Urothelial Cancer

Naoto Miyanaga, Hideyuki Akaza, Satoru Ishikawa, Mikinobu Ohlani, Ryosuke Noguchi, Koji Kawai, Kenkichi Koiso, Masaki Kobayashi, Akio Koyama, Takenori Takahashi

Open publisher page 129 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

OpenAlex reports 129 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Medicine, Urothelial cancer, Urine, Cytology, Urology, Urinary system, Urine cytology, Cancer

Back to paper search Browse research topics Original source

Clinical Evaluation of Nuclear Matrix Protein 22 (NMP22) in Urine as a Novel Marker for Urothelial Cancer — Research Paper | ScholarLens